Which Weight Management Injection Offers Better Value?
Wegovy vs Mounjaro Cost: Understanding the Key Differences
The wegovy vs mounjaro cost comparison reveals distinct pricing structures reflecting their different mechanisms and dosing schedules. Wegovy (semaglutide) follows a 5-dose escalation from 0.25mg to 2.4mg maintenance, while Mounjaro (tirzepatide) uses 6 doses ranging from 2.5mg to 15mg. Both prescription-only medicines require clinical assessment and work alongside a reduced-calorie diet and increased physical activity. The fundamental difference lies in their receptor targeting: Wegovy acts solely on GLP-1 receptors, whereas Mounjaro provides dual GLP-1 and GIP receptor activation.
When evaluating wegovy vs mounjaro cost implications, consider the total treatment duration and maintenance requirements. Wegovy's proven STEP trial data shows sustained weight management at the 2.4mg maintenance dose, while Mounjaro's SURMOUNT trials demonstrate effectiveness across its dosing range. Both treatments are available through EverydayMeds' streamlined online service, with prescriber review determining the most appropriate option based on your individual clinical profile and cost considerations.
Wegovy vs Mounjaro Cost: Detailed Pricing Breakdown
EverydayMeds offers transparent wegovy vs mounjaro cost structures with Wegovy single pens priced from £79.99 (0.25mg starter) to £209.99 (2.4mg maintenance). Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) cost £169.99, while the Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. New customers apply code FIRST40 at checkout to reach these competitive prices, with returning customers using DOSE25. Bundle pricing offers convenience through Reliable Supply continuity and reduced ordering frequency.
Mounjaro pricing follows a similar escalation pattern but with different dose strengths and intervals, making direct wegovy vs mounjaro cost comparison complex without prescriber guidance. Both treatments represent significant investment in long-term weight management, but clinical evidence from STEP and SURMOUNT trials respectively demonstrates sustained effectiveness when used as prescribed. EverydayMeds' GPhC-registered pharmacy (#9012878) ensures both options meet UK quality standards with next-day cold-chain delivery maintaining medication integrity.
Clinical Evidence Shaping Wegovy vs Mounjaro Cost Decisions
The wegovy vs mounjaro cost evaluation benefits from robust clinical evidence supporting both treatments' effectiveness. Wegovy's STEP 1 trial demonstrated approximately 15% average weight loss at 68 weeks when patients used the medication alongside diet and exercise modifications (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further showed 20% reduction in major cardiovascular events, adding clinical value beyond weight management alone.
Mounjaro's SURMOUNT trial programme provides comparable evidence for tirzepatide's dual receptor approach, though direct head-to-head comparisons remain limited due to different trial designs and populations. When considering wegovy vs mounjaro cost against clinical outcomes, both treatments require long-term commitment as STEP 1 extension data indicates patients may regain approximately two-thirds of lost weight within one year of stopping treatment.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding Wegovy's mechanism helps justify its position in wegovy vs mounjaro cost discussions. Semaglutide mimics the natural GLP-1 hormone produced in your intestines after eating, signalling fullness to brain appetite centres and slowing gastric emptying. This dual action reduces appetite while promoting sustained satiety after smaller meal portions. The once-weekly FlexTouch pen delivers consistent medication levels, supporting gradual dose escalation from 0.25mg starter through to 2.4mg maintenance. Clinical assessment ensures appropriate patient selection, as Wegovy is licensed for adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. The prescription-only medicine status reflects its potent mechanism requiring medical supervision throughout treatment.
EverydayMeds Ordering Process: Simple Access to Both Treatments
Our streamlined wegovy vs mounjaro cost comparison extends to identical ordering processes for both treatments. Complete our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Qualified prescribers review applications within 3 working days (express 24-hour service available), determining treatment suitability based on NICE guidelines and individual patient factors. Once approved, next-day delivery uses temperature-controlled cold-chain logistics maintaining medication stability. The GPhC-registered pharmacy (#9012878) ensures regulatory compliance throughout the supply chain. Payment options include single pen purchases or convenient bundle packages, with discount codes FIRST40 (new customers) and DOSE25 (returning customers) applied at checkout.
Storage and Practical Considerations in Wegovy vs Mounjaro Cost Analysis
Storage requirements significantly impact wegovy vs mounjaro cost of ownership beyond initial purchase prices. Wegovy offers superior travel convenience, remaining stable for 6 weeks at room temperature below 30°C once removed from fridge storage, compared to Mounjaro's 21-day room temperature limit. Both require refrigeration at 2-8°C before first use, but Wegovy's extended stability reduces wastage risk during holidays or business travel. The FlexTouch pen system provides reliable dose delivery with clear dose escalation markings. Pre-filled pens eliminate mixing or preparation steps, supporting treatment adherence. Proper storage maintains medication potency throughout the escalation schedule, ensuring optimal clinical outcomes justify the investment.
Dual vs Single Receptor Targeting: Value Proposition Analysis
The wegovy vs mounjaro cost debate centres partly on receptor targeting approaches and their relative value. Wegovy's selective GLP-1 receptor activation provides established weight management benefits with extensive real-world usage data since UK approval. Mounjaro's dual GLP-1 and GIP receptor mechanism offers theoretical advantages through complementary metabolic pathways, though long-term comparative data remains limited. Both approaches demonstrate clinically meaningful weight loss in their respective trial programmes when used alongside lifestyle modifications.
Cost-effectiveness considerations extend beyond initial wegovy vs mounjaro cost comparisons to include treatment durability and maintenance requirements. Neither treatment offers permanent weight loss solutions, requiring ongoing commitment and potential dose adjustments based on individual response. EverydayMeds stocks both options, allowing prescribers flexibility in treatment selection based on patient preferences, clinical factors, and budget considerations rather than pharmacy availability constraints.
Making Your Choice: Expert Guidance on Treatment Selection
Resolving the wegovy vs mounjaro cost dilemma requires professional guidance considering individual circumstances beyond pricing alone. Our qualified prescribers evaluate medical history, concurrent medications, weight loss goals, and practical factors like travel requirements or injection preferences. Both treatments represent proven approaches to weight management, but patient-specific factors may favour one option over another. The online consultation process ensures comprehensive assessment while maintaining privacy and convenience. Treatment selection considers both immediate wegovy vs mounjaro cost implications and long-term value through sustained weight management support. Both Wegovy and Mounjaro are available from EverydayMeds - your prescriber can help determine which treatment pathway aligns with your clinical needs and financial considerations for optimal long-term outcomes.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
